Combat Drugs (India) Financial Indicators Patterns

COMBDRG -- India Stock  

INR 20.40  0.00  0.00%

Use fundamental data analysis to double-check all available reported financial drivers of Combat Drugs Limited to find out if markets are presently mispricing the company. We found thirty-one available fundamental indicators for Combat Drugs Limited which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Combat Drugs Limited fundamentals including its Cash and Equivalents, Cash Flow from Operations and the relationship between Gross Profit and Debt to Equity . Use Combat Drugs to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Combat Drugs to be traded at 20.2 in 30 days.

Combat Drugs Company Summary

Combat Drugs competes with Piramal Enterprises, Cipla, Cipla, Torrent Pharmaceuticals, and Abbott India. Combat Drugs Limited manufactures and markets pharmaceutical formulations in India. The company was founded in 1986 and is based in Hyderabad, India. Combat Drugs is traded on Bombay Stock Exchange in India.

Combat Drugs Shares Outstanding vs Retained Earnings

Combat Drugs Limited is rated below average in shares outstanding category among related companies. It is rated below average in retained earnings category among related companies .

Combat Drugs Market Fundamentals

 Change(%) 0.00%

Distress Rating

Combat Drugs Financial Distress Probability

Chance of Financial Distress
Combat Drugs Limited has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Combat Drugs Opportunity Range

January 16, 2019 Opportunity Range

Check also Trending Equities. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.